Cat
Name
Size
Price
Action
ME482a
Skin malignant melanoma tissue array with adjacent normal or normal skin tissue as control, 48 cases/ 48 cores, replacing ME482-ME482a
each
Ask
MBS8119651-01
SARS-CoV-2 (2019-nCoV) Spike S1+S2 ECD (R683A, R685A, F817P, A892P, A899P, A942P, K986P, V987P)-His Recombinant HEK293 Cell Lysate (WB positive control)
0.3 mg
Ask
MBS8119651-02
SARS-CoV-2 (2019-nCoV) Spike S1+S2 ECD (R683A, R685A, F817P, A892P, A899P, A942P, K986P, V987P)-His Recombinant HEK293 Cell Lysate (WB positive control)
5x 0.3 mg
Ask
LC807b
Lung cancer tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, cases/ cores, replacing LC807a-LC807b
each
Ask
OV702b
Ovary cancer tissue array with adjacent normal tissue as control, including TNM and pathology grade, 70 cases/70 cores, replacing OV702a-OV702b
each
Ask
RE1504
Rectum cancer tissue array with matched cancer adjacent tissue as control, including TNM, clinical stage and pathology grade, 50 cases/ 150 cores-RE1504
each
Ask
T072b
Kidney cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replacing T072a-T072b
each
Ask
MBS645343-01
SEPT4 (Septin-4, Peanut-like Protein 2, Brain Protein H5, Cell Division Control-related Protein 2, hCDCREL-2, Bradeion beta, CE5B3 beta, Cerebral Protein 7, hucep-7, SEP4, PNUTL2)
0.1 mg
Ask
MBS645343-02
SEPT4 (Septin-4, Peanut-like Protein 2, Brain Protein H5, Cell Division Control-related Protein 2, hCDCREL-2, Bradeion beta, CE5B3 beta, Cerebral Protein 7, hucep-7, SEP4, PNUTL2)
5x 0.1 mg
Ask
MBS6010987-01
SEPT4 (Septin-4, Peanut-like Protein 2, Brain Protein H5, Cell Division Control-related Protein 2, hCDCREL-2, Bradeion beta, CE5B3 beta, Cerebral Protein 7, hucep-7, SEP4, PNUTL2)
0.1 mg
Ask
MBS6010987-02
SEPT4 (Septin-4, Peanut-like Protein 2, Brain Protein H5, Cell Division Control-related Protein 2, hCDCREL-2, Bradeion beta, CE5B3 beta, Cerebral Protein 7, hucep-7, SEP4, PNUTL2)
5x 0.1 mg
Ask
ES482a
Esophageal cancer tissue array with esophagus tissue as control, including TNM, clinical stage and pathology grade, 48 cases/ 48 cores, replacing ES482-ES482a
each
Ask
BR1002b
Breast cancer tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 100 cases/ 100 cores, replacing BR1002a-BR1002b
each
Ask
T053b
Colon tumor test tissue array, with normal colon tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases/12 cores, replaced by T053c-T053b
each
Ask
CO242b
Colon carcinoma tissue array with adjacent normal colon tissue as control, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replacing CO242a-CO242b
each
Ask
CO722
Colon adenocarcinoma tissue array with matched tumor adjacent and adjacent normal tissue control, with stage and grade info, 24 cases/72 cores, replacing BC05021-CO722
each
Ask
Her2d
Her-2 IHC Bio-marker control tissue array of breast invasive ductal carcinoma, including pathology grade, TNM and clinical stage, 10 cases/ 10 cores, replacing Her2c-Her2d
each
Ask
T191b
Prostate adenocarcinoma test tissue array, with prostate control tissues, pathology grade, TNM and clinical stage (AJCC 8.0), 6 cases/24 cores, replacing T191a (1.5mm)-T191b
each
Ask
T033b
Liver cancer tissue array with normal liver tissue as control, including pathology grade, TNM and clinical stage, 2 serial sections, 6 cases/ 24 cores, replacing T033a-T033b
each
Ask
LC242b
Non-small cell lung carcinoma NSCLC tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replacing LC242a-LC242b
each
Ask
BC05012b
Colon cancer tissue array with cancer adjacent normal tissue as control, including TNM, clinical stage and pathology grade, 72 cases/72 cores, replacing BC05012a-BC05012b
each
Ask
PM2a-ER
Breast cancer with ER Immunohistochemistry control tissue array, including pathology grade, TNM, clinical stage and IHC results of ER/PR/Her-2/Ki67, 10 cases/10 cores, replacing PM2-ER-PM2a-ER
each
Ask
HER2c
Her-2 IHC Bio-marker control TMA, with breast invasive carcinoma of no special type, including pathology grade, TNM, clinical stage and IHC markers (ER, PR, Her-2 and Ki-67) results, 10 cases/10 cores, replacing Her2b
10 Cases / 10 Cores
Ask
CO1005a
Colon carcinoma, metastatic carcinoma and colon adenoma tissue array with colon tissue as control, including pathology grade, TNM and clinical stage (reference AJCC 8th version), 98 cases/100 cores, replacing CO1005-CO1005a
each
Ask
CO20811a
Colon cancer tissue array with normal colon tissue and adjacent colon tissue as control, including TNM and pathology grade with MMR (MLH1/PMS2/MSH2/MSH6 2017 Ventana MMR kit) IHC results, 208 cases/ 208 cores, replacing CO20811-CO20811a
each
Ask
CO2081b
Colon disease spectrum with normal tissue array as control, including TNM, clinical stage and pathology grade with MMR (MLH1/PMS2/MSH2/MSH6 2017 Ventana MMR kit) IHC results, containing 34 cases of adenocarcinoma, 2 carcinoid, 20 metastatic carcinoma, 5 each of adenoma and polyp, 8 hyperplasia, 10 each of inflammation, 104 cases/ 208 cores, replacing CO2081a-CO2081b
each
Ask
TL301830V
SBF2 Human shRNA Lentiviral Particle (Locus ID 81846)
500 µL Each
Ask
TL710567V
Nrbf2 Rat shRNA Lentiviral Particle (Locus ID 58839)
500 µL Each
Ask
TL509131V
Nrbf2 Mouse shRNA Lentiviral Particle (Locus ID 641340)
500 µL Each
Ask
TL321477V
ZDBF2 Human shRNA Lentiviral Particle (Locus ID 57683)
500 µL Each
Ask
TL302890V
NRBF2 Human shRNA Lentiviral Particle (Locus ID 29982)
500 µL Each
Ask